Detalles de la búsqueda
1.
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
PLoS Pathog
; 20(4): e1011680, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38635853
2.
Characterization of treatment resistance and viral kinetics in the setting of single- versus dual-active monoclonal antibodies against SARS-CoV-2.
J Infect Dis
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716969
3.
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester.
Clin Infect Dis
; 78(3): 667-673, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768207
4.
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Clin Infect Dis
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739755
5.
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
Ann Intern Med
; 176(3): 348-354, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802755
6.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Ann Intern Med
; 176(5): 658-666, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068272
7.
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
J Infect Dis
; 228(Suppl 2): S77-S82, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650231
8.
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
J Infect Dis
; 228(Suppl 2): S92-S100, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650234
9.
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
J Infect Dis
; 228(Suppl 2): S83-S91, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650237
10.
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
J Infect Dis
; 228(2): 133-142, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661240
11.
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
J Infect Dis
; 228(Suppl 2): S117-S125, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650230
12.
Variant-Specific Viral Kinetics in Acute COVID-19.
J Infect Dis
; 228(Suppl 2): S136-S143, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650233
13.
Immune Status and SARS-CoV-2 Viral Dynamics.
J Infect Dis
; 228(Suppl 2): S111-S116, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650232
14.
Long COVID After Bamlanivimab Treatment.
J Infect Dis
; 228(Suppl 2): S126-S135, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650236
15.
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.
J Infect Dis
; 228(Suppl 2): S101-S110, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650235
16.
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.
Clin Infect Dis
; 76(4): 734-737, 2023 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36210483
17.
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
Clin Infect Dis
; 77(7): 941-949, 2023 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279602
18.
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.
Clin Infect Dis
; 77(6): 892-900, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227925
19.
Iron status among HIV-infected adults during the first year of antiretroviral therapy in Tanzania.
HIV Med
; 24(4): 398-410, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36075691
20.
The effect of iron supplementation on maternal iron deficiency anemia does not differ by baseline anemia type among Tanzanian pregnant women without severe iron deficiency anemia.
Eur J Nutr
; 62(2): 987-1001, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36344770